considerable fraction of diseases with onset early in life appear to result from defects in enzyme-encoding genes, whereas diseases with onset during adulthood appear to be caused by alterations in genes encoding modifiers of protein functions [9] . Thus, clinical information such as age at onset or severity can serve as valuable expert knowledge to narrow down the genomic search space to genes or genetic domains that are biologically and clinically meaningful. Additionally, and although this is not always the case, co-morbid disorders often share genes [6] . Hence, using well-established susceptibility loci for co-morbid disorders as a starting point in genetic association studies may further enhance the success rate of these endeavors.
Recent years have come with major advancements in candidate gene prioritization and our understanding of the genetic architecture of human diseases is undoubtedly progressing. Here we have suggested that biological and clinical information may serve as valuable expert knowledge for genetic association studies and that disease networks may provide useful guidance prior to and during data mining. 
